Pre-Market Earnings Report for November 3, 2025 : IDXX, PEG, RYAAY, ARES, BNTX, ON, CNA, PNW, CIFR, AMG, AXSM, BRKR

On November 3, 2025, a diverse group of companies is slated to report Q3 2025 earnings, with analyst consensus forecasts revealing a mixed performance outlook. IDEXX Laboratories (IDXX) is anticipated to post a 12.14% EPS increase, supported by a high forward P/E ratio of 49.84 relative to its industry, while Ares Management (ARES) and Ryanair (RYAAY) also project substantial EPS growth. In contrast, BioNTech (BNTX) and ON Semiconductor (ON) are expected to report significant year-over-year EPS declines of 15.73% and 40.40% respectively, with BNTX's negative P/E ratio signaling particular headwinds, underscoring varied growth trajectories across sectors.

Analysis

A diverse group of companies is set to report Q3 2025 earnings on November 3rd, presenting a mixed outlook based on analyst consensus. While several firms project robust year-over-year EPS growth, others face significant declines and valuation challenges. The overall sentiment across these reports is mixed, with a low to moderate market impact anticipated.

IDEXX Laboratories (IDXX) stands out with a projected 12.14% EPS increase and a strong track record of beating expectations, reflected in its 49.84 P/E ratio significantly above the industry's 2.20. Ares Management (ARES) and Public Service Enterprise Group (PEG) also show solid growth forecasts of 20.00% and 12.22% respectively, with PEG's P/E of 20.09 slightly exceeding its industry average. Affiliated Managers Group (AMG) anticipates a 20.95% EPS increase, having consistently met or beaten expectations.

Conversely, BioNTech (BNTX) and ON Semiconductor (ON) are expected to report substantial EPS decreases of 15.73% and 40.40% year-over-year, respectively, with BNTX's negative P/E of -26.43 indicating significant headwinds. Pinnacle West Capital (PNW) and Bruker Corporation (BRKR) also face projected EPS declines of 9.79% and 45.00%, while Cipher Mining (CIFR) and Axsome Therapeutics (AXSM) continue to forecast negative EPS, coupled with prior significant misses and negative P/E ratios. These companies generally exhibit lower analyst sentiment and recent earnings misses.

Key Decisions for Investors

• Investors should prioritize companies like IDXX, ARES, and PEG exhibiting strong positive EPS growth and favorable P/E ratios relative to their industries, especially those with a history of beating estimates.
• Exercise caution with underperformers such as BNTX, ON, PNW, CIFR, AXSM, and BRKR, given their projected EPS declines, negative P/E ratios, and history of missing consensus, which may signal ongoing operational challenges or valuation concerns.
• Monitor post-earnings guidance for all reporting companies, as management commentary will provide crucial context for current forecasts and future growth trajectories, particularly for those with mixed or negative outlooks.